Clinical trial · Observational
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
NCT07527143CI-TRIAL-00117358recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Carcinoma | Endometrial Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional Study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Participants complete a semi-structured interview on study.
- interventionNames
- Other: Non-Interventional Study
Primary outcomes (1)
- measure
- Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test
- timeFrame
- Baseline (30-minute virtual interview)
- description
- Information collected during a 30-minute virtual interview using mostly open-ended questions. The interviews will be transcribed and reviewed by the study team to identity themes and create coding categories. Coding categories will be used to organize the data into subthemes. Results will be reported in aggregate. Aggregate results will be disseminated to participants if they elect to receive them.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Self-identified Black individuals ≥ 45 years with an intact uterus * Assigned female sex at birth * Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause) * Willing to participate in a 45-minute virtual interview Exclusion Criteria: * Previous or current diagnosis of endometrial cancer
References
Publications (0)
Data not yet available
No reference posted for this study.